Computing Drug-Drug Similarity from Patient-Centric Data

Bioengineering (Basel). 2023 Feb 1;10(2):182. doi: 10.3390/bioengineering10020182.

Abstract

In modern biology and medicine, drug-drug similarity is a major task with various applications in pharmaceutical drug development. Various direct and indirect sources of evidence obtained from drug-centric data such as side effects, drug interactions, biological targets, and chemical structures are used in the current methods to measure the level of drug-drug similarity. This paper proposes a computational method to measure drug-drug similarity using a novel source of evidence that is obtained from patient-centric data. More specifically, patients' narration of their thoughts, opinions, and experience with drugs in social media are explored as a potential source to compute drug-drug similarity. Online healthcare communities were used to extract a dataset of patients' reviews on anti-epileptic drugs. The collected dataset is preprocessed through Natural Language Processing (NLP) techniques and four text similarity methods are applied to measure the similarities among them. The obtained similarities are then used to generate drug-drug similarity-based ranking matrices which are analyzed through Pearson correlation, to answer questions related to the overall drug-drug similarity and the accuracy of the four similarity measures. To evaluate the obtained drug-drug similarities, they are compared with the corresponding ground-truth similarities obtained from DrugSimDB, a well-known drug-drug similarity tool that is based on drug-centric data. The results provide evidence on the feasibility of patient-centric data from social media as a novel source for computing drug-drug similarity.

Keywords: drug-drug similarity; natural language processing; online healthcare communities; social media; text-based analysis.